Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Biochemistry
|
February 26, 2003
Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation
Mithua Ghosh, Keven Huang, Steven J Berberich
Cell Cycle (Georgetown, Tex.)
|
May 7, 2005
MdmX inhibits ARF mediated Mdm2 sumoylation
Mithua Ghosh, Karen Weghorst, Steven J Berberich
Cell Cycle (Georgetown, Tex.)
|
January 24, 2004
MdmX represses E2F1 transactivation
Mark Wunderlich, Mithua Ghosh, Karen Weghorst, et al.
Oral Oncology
|
February 22, 2020
Molecular landscape of salivary gland cancers
Ankita Kar, Adegbola Adeniji, Vishal U S Rao, et al.
Advances in Therapy
|
March 14, 2019
Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing
Kumar Prabhash, Suresh H Advani, Ullas Batra, et al.
Journal of Cancer Research and Therapeutics
|
April 3, 2023
The role of p53 and ki67 in predicting clinical outcome in breast cancer patients
Bhanu Prakash Lalkota, B J Srinivasa, Mani V Swamy, et al.
Journal of Cancer Research and Therapeutics
|
October 3, 2023
Molecular epidemiology and clinical characteristics of epidermal growth factor receptor mutations in NSCLC: A single-center experience from India
Renjan Thomas, Gautam Balaram, Hrish Varayathu, et al.
Journal of Human Genetics
|
February 26, 2016
Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India
Ashraf U Mannan, Jaya Singh, Ravikiran Lakshmikeshava, et al.
Scientific Reports
|
April 11, 2025
Comprehensive genomic profiling reveals a unique genomic landscape in solid tumors in an Indian cancer cohort of 1000 patients: a single institutional experience
Mithua Ghosh, Sheela Mysore Lingaraju, Krishna C R, et al.
Translational Oncology
|
October 25, 2020
Landscape of clinically actionable mutations in breast cancer 'A cohort study'
Mithua Ghosh, Radheshyam Naik, Sheela Mysore Lingaraju, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Biochemistry
|
February 26, 2003
Overexpression of Mdm2 and MdmX fusion proteins alters p53 mediated transactivation, ubiquitination, and degradation
Mithua Ghosh, Keven Huang, Steven J Berberich
Cell Cycle (Georgetown, Tex.)
|
May 7, 2005
MdmX inhibits ARF mediated Mdm2 sumoylation
Mithua Ghosh, Karen Weghorst, Steven J Berberich
Cell Cycle (Georgetown, Tex.)
|
January 24, 2004
MdmX represses E2F1 transactivation
Mark Wunderlich, Mithua Ghosh, Karen Weghorst, et al.
Oral Oncology
|
February 22, 2020
Molecular landscape of salivary gland cancers
Ankita Kar, Adegbola Adeniji, Vishal U S Rao, et al.
Advances in Therapy
|
March 14, 2019
Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular Testing
Kumar Prabhash, Suresh H Advani, Ullas Batra, et al.
Journal of Cancer Research and Therapeutics
|
April 3, 2023
The role of p53 and ki67 in predicting clinical outcome in breast cancer patients
Bhanu Prakash Lalkota, B J Srinivasa, Mani V Swamy, et al.
Journal of Cancer Research and Therapeutics
|
October 3, 2023
Molecular epidemiology and clinical characteristics of epidermal growth factor receptor mutations in NSCLC: A single-center experience from India
Renjan Thomas, Gautam Balaram, Hrish Varayathu, et al.
Journal of Human Genetics
|
February 26, 2016
Detection of high frequency of mutations in a breast and/or ovarian cancer cohort: implications of embracing a multi-gene panel in molecular diagnosis in India
Ashraf U Mannan, Jaya Singh, Ravikiran Lakshmikeshava, et al.
Scientific Reports
|
April 11, 2025
Comprehensive genomic profiling reveals a unique genomic landscape in solid tumors in an Indian cancer cohort of 1000 patients: a single institutional experience
Mithua Ghosh, Sheela Mysore Lingaraju, Krishna C R, et al.
Translational Oncology
|
October 25, 2020
Landscape of clinically actionable mutations in breast cancer 'A cohort study'
Mithua Ghosh, Radheshyam Naik, Sheela Mysore Lingaraju, et al.
Page
of 2